Rb Regulates DNA Damage Response and Cellular Senescence through E2F-Dependent Suppression of N-Ras Isoprenylation

被引:107
作者
Shamma, Awad [1 ,2 ]
Takegami, Yujiro [1 ]
Miki, Takao [1 ,2 ]
Kitajima, Shunsuke [1 ]
Noda, Makoto [1 ]
Obara, Takao [3 ]
Okamoto, Takahiro [3 ]
Takahashi, Chiaki [1 ,2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, 21st Century Ctr Excellence Format, Kyoto 6068501, Japan
[3] Tokyo Womens Med Univ, Dept Endocrine Surg, Tokyo 1668666, Japan
关键词
RETINOBLASTOMA PROTEIN; CYCLE PROGRESSION; INACTIVATION; E2F; DIFFERENTIATION; PATHWAY; BINDING; ACTIVATION; DEFECTS; INDUCE;
D O I
10.1016/j.ccr.2009.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogene-induced cellular senescence is well documented, but little is known about how infinite cell proliferation induced by loss of tumor suppressor genes is antagonized by cellular functions. Rb heterozygous mice generate Rb-deficient C cell adenomas that progress to adenocarcinomas following biallelic loss of N-ras. Here, we demonstrate that pRb inactivation induces aberrant expression of farnesyl diphosphate synthase, many prenyltransferases, and their upstream regulators sterol regulatory element-binding proteins (SREBPs) in an E2F-dependent manner, leading to enhanced isoprenylation and activation of N-Ras. Consequently, elevated N-Ras activity induces DNA damage response and p130-dependent cellular senescence in Rb-deficient cells. Furthermore, Rb heterozygous mice additionally lacking any of Ink4a, Arf, or Suv39h1 generated C cell adenocarcinomas, suggesting that cellular senescence antagonizes Rb-deficient carcinogenesis.
引用
收藏
页码:255 / 269
页数:15
相关论文
共 45 条
  • [1] Andres DA, 1999, METH MOL B, V116, P107
  • [2] dpl-1 DP and efl-1 E2F act with lin-35 Rb to antagonize Ras signaling in C-elegans vulval development
    Ceol, CJ
    Horvitz, HR
    [J]. MOLECULAR CELL, 2001, 7 (03) : 461 - 473
  • [3] Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
    Chen, ZB
    Trotman, LC
    Shaffer, D
    Lin, HK
    Dotan, ZA
    Niki, M
    Koutcher, JA
    Scher, HI
    Ludwig, T
    Gerald, W
    Cordon-Cardo, C
    Pandolfi, PP
    [J]. NATURE, 2005, 436 (7051) : 725 - 730
  • [4] Cellular senescence in cancer and aging
    Collado, Manuel
    Blasco, Maria A.
    Serrano, Manuel
    [J]. CELL, 2007, 130 (02) : 223 - 233
  • [5] A negative feedback signaling network underlies oncogene-induced senescence
    Courtois-Cox, Stephanie
    Williams, Sybil M. Genther
    Reczek, Elizabeth E.
    Johnson, Bryan W.
    McGillicuddy, Lauren T.
    Johannessen, Cory M.
    Hollstein, Pablo E.
    MacCollin, Mia
    Cichowski, Karen
    [J]. CANCER CELL, 2006, 10 (06) : 459 - 472
  • [6] RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer
    Coxon, AB
    Ward, JM
    Geradts, J
    Otterson, GA
    Zajac-Kaye, M
    Kaye, FJ
    [J]. ONCOGENE, 1998, 17 (12) : 1625 - 1628
  • [7] Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland
    Denchi, EL
    Attwooll, C
    Pasini, D
    Helin, K
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (07) : 2660 - 2672
  • [8] Breaking news: high-speed race ends in arrest - how oncogenes induce senescence
    Di Micco, Raffaella
    Fumagalli, Marzia
    di Fagagna, Fabrizio d'Adda
    [J]. TRENDS IN CELL BIOLOGY, 2007, 17 (11) : 529 - 536
  • [9] What has senescence got to do with cancer?
    Dimri, GP
    [J]. CANCER CELL, 2005, 7 (06) : 505 - 512
  • [10] Deregulated E2f-2 underlies cell cycle and maturation defects in retinoblastoma null erythroblasts
    Dirlam, Alexandra
    Spike, Benjamin T.
    Macleod, Kay F.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (24) : 8713 - 8728